Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 6,700 shares, a growth of 116.1% from the January 31st total of 3,100 shares. Based on an average trading volume of 11,500 shares, the days-to-cover ratio is currently 0.6 days.
Invesco Nasdaq Biotechnology ETF Stock Performance
Shares of IBBQ stock traded up $0.34 during trading hours on Friday, reaching $22.59. The company had a trading volume of 5,343 shares, compared to its average volume of 11,983. The business has a fifty day moving average price of $22.17 and a 200-day moving average price of $23.07. Invesco Nasdaq Biotechnology ETF has a one year low of $20.14 and a one year high of $24.84. The firm has a market cap of $39.98 million, a PE ratio of 17.39 and a beta of 0.61.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
The firm also recently announced a dividend, which was paid on Friday, December 27th. Investors of record on Monday, December 23rd were given a dividend of $0.0619 per share. The ex-dividend date was Monday, December 23rd.
Institutional Trading of Invesco Nasdaq Biotechnology ETF
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
See Also
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- 3 Warren Buffett Stocks to Buy Now
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Overbought Stocks Explained: Should You Trade Them?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Canada Bond Market Holiday: How to Invest and Trade
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.